# Metabiota

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metabiota

- Industry: Healthcare
- Headquarters: San Francisco, US
- Website: www.metabiota.com
- Total disclosed funding: $31M
- Latest round: Series A (Sep 24, 2015)
- Investors on record: 7

## About

Metabiota, Inc. is a health technology company focused on enhancing individual well-being through personalized health solutions, offering tailored nutrition guidance and wellness strategies backed by scientific research.Founded in 2008, Metabiota, Inc. is based in San Francisco, US, and specializes in health and wellness solutions. The company was established by Nathan Wolfe. In February 2017, it successfully raised USD 12 mn in SERIES B funding, reaching a post-money valuation of USD 150.25 mn. Metabiota has completed a total of 6 deals.Metabiota Health specializes in comprehensive health and wellness solutions that enhance individual well-being through personalized nutrition guidance, lifestyle modifications, and targeted dietary supplement advice. Their core offerings include tailored health plans addressing various aspects of physical, mental, and overall wellness, leveraging the latest scientific research for evidence-based recommendations. The company serves a diverse client base including health-conscious individuals and organizations focused on improving community health standards, with initiatives extending globally, particularly in North America, Europe, and parts of Asia.Metabiota Health generates revenue through a combination of direct-to-consumer services and partnerships within the health and wellness sector. Their business model includes one-on-one consultations, workshops, and subscription-based access to personalized resources and plans. Clients engage with Metabiota's services by purchasing tailored health plans designed to meet their individual health goals and challenges, with pricing structured based on the complexity and scope of services provided, effectively building long-term client relationships.Following the SERIES B financing in February 2017, which raised USD 12 mn, Metabiota, Inc. is focused on expanding its product offerings and entering new markets. The company intends to enhance its health solutions portfolio with upcoming products designed to meet evolving client needs. Specific geographic regions targeted for expansion include additional markets in North America and Europe. The recent funding will be utilized to support the development of these new products and to facilitate the company's entry into these new markets.

## Funding rounds

- Series A, Sep 24, 2015, $1M — GV
- Series A, Dec 23, 2014, $30M — Industry Ventures, WP Global Partners, DCVC, Pilot Growth Equity, Martis Capital
- Seed, Jun 1, 2008 — Skoll Foundation, GV

## Investors

- Skoll Foundation — Seed
- GV (https://capitalatlas.ai/funds/gv) — Seed, Series A
- Industry Ventures (https://capitalatlas.ai/funds/industry-ventures) — Series A
- WP Global Partners — Series A
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series A
- Pilot Growth Equity (https://capitalatlas.ai/funds/pilot-growth-equity) — Series A
- Martis Capital (https://capitalatlas.ai/funds/martis-capital) — Series A